跳至主要内容
临床试验/CTRI/2025/09/094694
CTRI/2025/09/094694尚未招募3 期

To Ascertain The Efficacy Of Streptococcinum As An Intercurrent Remedy In Reducing The Recurrency Of Tonsillitis In Paediatric Age Group(3–15 Years): A Parallel Arm, Randomized Controlled Trial

Dr Madan Pratap Khunteta Homoeopathic Medical College Hospital And Research Centre1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月22日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1. The study is expected to show the effectiveness of Streptococcinum as an

研究概览

简要总结

his research is a randomized controlled trial conducted in children aged 3 to 15 years with recurrent tonsillitis to ascertain the role of Streptococcinum as an intercurrent remedy along with individualized homoeopathic treatment in minimizing recurrence and improving overall outcomes in terms of frequency intensity and duration of episodes

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
3.00 Year(s) 至 15.00 Year(s)(—)
性别
All

入选标准

  • Age 3–15 years
  • equal or more than 3 episodes in 6 months or equalor more than 5 in a year
  • Informed written consent and assent from guardians/parents/child
  • Each episode of tonsillitis must include one or more of the following, in addition to a sore throat: a.
  • Temperature of 38.3°C (100.9°F) or higher.
  • Tender cervical adenopathy (swollen lymph nodes in the neck).
  • Tonsillar exudates (pus on the tonsils).
  • A positive culture for Group A beta-hemolytic streptococcus (the bacteria that causes strep throat
  • Cases of recurrent tonsilitis ICD 11(CA0F.Y) and ICD 10(J35.0).

排除标准

  • Acute tonsillitis at time of enrolment
  • Systemic chronic illness or immune disorders
  • Current use of other complementary therapies.

结局指标

主要结局

1. The study is expected to show the effectiveness of Streptococcinum as an

时间窗: Evaluation of recurrent tonsillitis reported by the no. of episodes and the | intensity. | • Evaluation in every 2 weeks | • Study end point: 6 months after the last registered case

intercurrent remedy in reducing the cases of tonsillitis in children ages 3-15

时间窗: Evaluation of recurrent tonsillitis reported by the no. of episodes and the | intensity. | • Evaluation in every 2 weeks | • Study end point: 6 months after the last registered case

years.7,9,1

时间窗: Evaluation of recurrent tonsillitis reported by the no. of episodes and the | intensity. | • Evaluation in every 2 weeks | • Study end point: 6 months after the last registered case

2. The study is expected to show a comparison of the two groups, pointing

时间窗: Evaluation of recurrent tonsillitis reported by the no. of episodes and the | intensity. | • Evaluation in every 2 weeks | • Study end point: 6 months after the last registered case

out the difference in efficacy in the two groups and medicines used.

时间窗: Evaluation of recurrent tonsillitis reported by the no. of episodes and the | intensity. | • Evaluation in every 2 weeks | • Study end point: 6 months after the last registered case

3. The study will help to find the average duration of medication required in

时间窗: Evaluation of recurrent tonsillitis reported by the no. of episodes and the | intensity. | • Evaluation in every 2 weeks | • Study end point: 6 months after the last registered case

cases of recurrent tonsillitis in ages 3-15years

时间窗: Evaluation of recurrent tonsillitis reported by the no. of episodes and the | intensity. | • Evaluation in every 2 weeks | • Study end point: 6 months after the last registered case

次要结局

未报告次要终点

研究者

发起方
Dr Madan Pratap Khunteta Homoeopathic Medical College Hospital And Research Centre
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Vanshika

Dr Madan Pratap Khunteta Homoeopathic Medical College Hospital And Research Centre

研究点 (1)

Loading locations...

相似试验